Arthritis Research & Therapy

official impact factor 4.36

Rationale of using different biological therapies in rheumatoid arthritis

Matthias Geyer and Ulf Müller-Ladner*

Arthritis Research & Therapy 2010, 12:214 doi:10.1186/ar3102

Accesses  

  • Last 30 days: 61 accesses
  • Last 365 days: 1044 accesses
  • All time: 2375 accesses